nodes	percent_of_prediction	percent_of_DWPC	metapath
Adapalene—Papilloedema—Medroxyprogesterone Acetate—uterine cancer	0.0187	0.0629	CcSEcCtD
Adapalene—RXRA—renal system—uterine cancer	0.0144	0.0622	CbGeAlD
Adapalene—RARA—myometrium—uterine cancer	0.0136	0.0588	CbGeAlD
Adapalene—Herpes labialis—Epirubicin—uterine cancer	0.013	0.0436	CcSEcCtD
Adapalene—RXRB—decidua—uterine cancer	0.0121	0.0523	CbGeAlD
Adapalene—Herpes labialis—Doxorubicin—uterine cancer	0.012	0.0404	CcSEcCtD
Adapalene—RXRA—female reproductive system—uterine cancer	0.0115	0.0498	CbGeAlD
Adapalene—RARG—decidua—uterine cancer	0.0108	0.0464	CbGeAlD
Adapalene—Optic neuritis—Progesterone—uterine cancer	0.0107	0.0359	CcSEcCtD
Adapalene—RXRA—female gonad—uterine cancer	0.0105	0.0453	CbGeAlD
Adapalene—RARB—female reproductive system—uterine cancer	0.0104	0.0447	CbGeAlD
Adapalene—RARA—decidua—uterine cancer	0.0101	0.0436	CbGeAlD
Adapalene—RARA—renal system—uterine cancer	0.00992	0.0428	CbGeAlD
Adapalene—RARG—mammalian vulva—uterine cancer	0.00987	0.0426	CbGeAlD
Adapalene—Redness—Progesterone—uterine cancer	0.00974	0.0327	CcSEcCtD
Adapalene—Optic neuritis—Medroxyprogesterone Acetate—uterine cancer	0.00969	0.0325	CcSEcCtD
Adapalene—Seborrhoeic dermatitis—Progesterone—uterine cancer	0.00965	0.0324	CcSEcCtD
Adapalene—RARA—endometrium—uterine cancer	0.0096	0.0414	CbGeAlD
Adapalene—RARB—female gonad—uterine cancer	0.00943	0.0407	CbGeAlD
Adapalene—RARG—uterus—uterine cancer	0.0094	0.0406	CbGeAlD
Adapalene—RARB—vagina—uterine cancer	0.00937	0.0404	CbGeAlD
Adapalene—RARA—uterus—uterine cancer	0.00884	0.0382	CbGeAlD
Adapalene—RXRB—female gonad—uterine cancer	0.00867	0.0374	CbGeAlD
Adapalene—RXRB—vagina—uterine cancer	0.00861	0.0372	CbGeAlD
Adapalene—RARG—female reproductive system—uterine cancer	0.00845	0.0365	CbGeAlD
Adapalene—Oral herpes—Epirubicin—uterine cancer	0.008	0.0269	CcSEcCtD
Adapalene—RARA—female reproductive system—uterine cancer	0.00795	0.0343	CbGeAlD
Adapalene—RARG—female gonad—uterine cancer	0.00769	0.0332	CbGeAlD
Adapalene—RARG—vagina—uterine cancer	0.00765	0.033	CbGeAlD
Adapalene—Oral herpes—Doxorubicin—uterine cancer	0.0074	0.0249	CcSEcCtD
Adapalene—Skin discolouration—Progesterone—uterine cancer	0.00728	0.0244	CcSEcCtD
Adapalene—RARA—female gonad—uterine cancer	0.00723	0.0312	CbGeAlD
Adapalene—Herpes simplex—Progesterone—uterine cancer	0.00714	0.0239	CcSEcCtD
Adapalene—RARB—lymph node—uterine cancer	0.00606	0.0262	CbGeAlD
Adapalene—Optic neuritis—Etoposide—uterine cancer	0.00547	0.0184	CcSEcCtD
Adapalene—RARG—lymph node—uterine cancer	0.00495	0.0213	CbGeAlD
Adapalene—RARA—lymph node—uterine cancer	0.00465	0.0201	CbGeAlD
Adapalene—Face oedema—Progesterone—uterine cancer	0.00461	0.0155	CcSEcCtD
Adapalene—Face oedema—Medroxyprogesterone Acetate—uterine cancer	0.00418	0.014	CcSEcCtD
Adapalene—Dry skin—Medroxyprogesterone Acetate—uterine cancer	0.00396	0.0133	CcSEcCtD
Adapalene—Pain—Carboplatin—uterine cancer	0.00382	0.0128	CcSEcCtD
Adapalene—Skin discolouration—Etoposide—uterine cancer	0.00372	0.0125	CcSEcCtD
Adapalene—Conjunctivitis—Progesterone—uterine cancer	0.00358	0.012	CcSEcCtD
Adapalene—Vesiculobullous rash—Epirubicin—uterine cancer	0.00336	0.0113	CcSEcCtD
Adapalene—Hepatitis—Progesterone—uterine cancer	0.0033	0.0111	CcSEcCtD
Adapalene—RXRB—a6b1 and a6b4 Integrin signaling—MET—uterine cancer	0.00324	0.00689	CbGpPWpGaD
Adapalene—Skin exfoliation—Etoposide—uterine cancer	0.00321	0.0108	CcSEcCtD
Adapalene—RXRA—Nuclear Receptors—ESR2—uterine cancer	0.00317	0.00675	CbGpPWpGaD
Adapalene—Vesiculobullous rash—Doxorubicin—uterine cancer	0.00311	0.0104	CcSEcCtD
Adapalene—RXRG—Nuclear Receptor transcription pathway—ESR1—uterine cancer	0.0031	0.0066	CbGpPWpGaD
Adapalene—RARG—Retinoic acid receptors-mediated signaling—EP300—uterine cancer	0.0031	0.00659	CbGpPWpGaD
Adapalene—RXRA—The citric acid (TCA) cycle and respiratory electron transport—NDUFB11—uterine cancer	0.00307	0.00652	CbGpPWpGaD
Adapalene—Optic neuritis—Epirubicin—uterine cancer	0.00307	0.0103	CcSEcCtD
Adapalene—RARB—Nuclear Receptor transcription pathway—ESR1—uterine cancer	0.00304	0.00647	CbGpPWpGaD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—YWHAE—uterine cancer	0.003	0.00639	CbGpPWpGaD
Adapalene—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.00299	0.01	CcSEcCtD
Adapalene—RXRG—a6b1 and a6b4 Integrin signaling—CDH1—uterine cancer	0.00299	0.00635	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.00294	0.00624	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptor transcription pathway—ESR1—uterine cancer	0.00292	0.00621	CbGpPWpGaD
Adapalene—RXRB—Nuclear Receptor transcription pathway—ESR1—uterine cancer	0.00292	0.00621	CbGpPWpGaD
Adapalene—Keratitis—Epirubicin—uterine cancer	0.00291	0.00976	CcSEcCtD
Adapalene—Erythema—Progesterone—uterine cancer	0.00287	0.00965	CcSEcCtD
Adapalene—RXRA—Nuclear Receptor transcription pathway—PGR—uterine cancer	0.00285	0.00606	CbGpPWpGaD
Adapalene—Optic neuritis—Doxorubicin—uterine cancer	0.00284	0.00952	CcSEcCtD
Adapalene—RXRG—Retinoic acid receptors-mediated signaling—EP300—uterine cancer	0.00283	0.00602	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.00281	0.00598	CbGpPWpGaD
Adapalene—RXRB—a6b1 and a6b4 Integrin signaling—CDH1—uterine cancer	0.00281	0.00597	CbGpPWpGaD
Adapalene—Redness—Epirubicin—uterine cancer	0.00279	0.00937	CcSEcCtD
Adapalene—RARB—Retinoic acid receptors-mediated signaling—EP300—uterine cancer	0.00278	0.00591	CbGpPWpGaD
Adapalene—Seborrhoeic dermatitis—Epirubicin—uterine cancer	0.00277	0.00928	CcSEcCtD
Adapalene—RXRG—Adipogenesis—HMGA1—uterine cancer	0.00275	0.00585	CbGpPWpGaD
Adapalene—RXRA—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.00272	0.00578	CbGpPWpGaD
Adapalene—Burning sensation—Epirubicin—uterine cancer	0.00271	0.00911	CcSEcCtD
Adapalene—Keratitis—Doxorubicin—uterine cancer	0.00269	0.00903	CcSEcCtD
Adapalene—RXRB—Retinoic acid receptors-mediated signaling—EP300—uterine cancer	0.00266	0.00566	CbGpPWpGaD
Adapalene—RARA—Retinoic acid receptors-mediated signaling—EP300—uterine cancer	0.00266	0.00566	CbGpPWpGaD
Adapalene—Angioedema—Progesterone—uterine cancer	0.00263	0.00882	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.00262	0.00558	CbGpPWpGaD
Adapalene—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.0026	0.00874	CcSEcCtD
Adapalene—RARA—Adipogenesis—HMGA1—uterine cancer	0.00259	0.0055	CbGpPWpGaD
Adapalene—Redness—Doxorubicin—uterine cancer	0.00258	0.00867	CcSEcCtD
Adapalene—Seborrhoeic dermatitis—Doxorubicin—uterine cancer	0.00256	0.00859	CcSEcCtD
Adapalene—Dermatitis atopic—Epirubicin—uterine cancer	0.00255	0.00855	CcSEcCtD
Adapalene—RXRG—a6b1 and a6b4 Integrin signaling—ERBB2—uterine cancer	0.00252	0.00536	CbGpPWpGaD
Adapalene—Burning sensation—Doxorubicin—uterine cancer	0.00251	0.00843	CcSEcCtD
Adapalene—RXRA—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.00251	0.00533	CbGpPWpGaD
Adapalene—Convulsion—Progesterone—uterine cancer	0.00249	0.00836	CcSEcCtD
Adapalene—Feeling hot—Epirubicin—uterine cancer	0.0024	0.00806	CcSEcCtD
Adapalene—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00238	0.00799	CcSEcCtD
Adapalene—RXRB—a6b1 and a6b4 Integrin signaling—ERBB2—uterine cancer	0.00237	0.00504	CbGpPWpGaD
Adapalene—Rash pustular—Epirubicin—uterine cancer	0.00236	0.00793	CcSEcCtD
Adapalene—Dermatitis atopic—Doxorubicin—uterine cancer	0.00236	0.00791	CcSEcCtD
Adapalene—Hepatitis—Dactinomycin—uterine cancer	0.00233	0.00783	CcSEcCtD
Adapalene—Stinging—Epirubicin—uterine cancer	0.00233	0.00781	CcSEcCtD
Adapalene—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00226	0.00757	CcSEcCtD
Adapalene—Feeling hot—Doxorubicin—uterine cancer	0.00222	0.00746	CcSEcCtD
Adapalene—RXRA—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.0022	0.00469	CbGpPWpGaD
Adapalene—Rash pustular—Doxorubicin—uterine cancer	0.00219	0.00734	CcSEcCtD
Adapalene—Stinging—Doxorubicin—uterine cancer	0.00215	0.00723	CcSEcCtD
Adapalene—Skin discolouration—Epirubicin—uterine cancer	0.00209	0.00701	CcSEcCtD
Adapalene—RXRG—Adipogenesis—SOCS3—uterine cancer	0.00206	0.00438	CbGpPWpGaD
Adapalene—Herpes simplex—Epirubicin—uterine cancer	0.00205	0.00687	CcSEcCtD
Adapalene—Erythema—Dactinomycin—uterine cancer	0.00203	0.00682	CcSEcCtD
Adapalene—Pain—Progesterone—uterine cancer	0.00201	0.00673	CcSEcCtD
Adapalene—RXRA—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.002	0.00425	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—SOCS3—uterine cancer	0.00194	0.00412	CbGpPWpGaD
Adapalene—Skin discolouration—Doxorubicin—uterine cancer	0.00193	0.00648	CcSEcCtD
Adapalene—RXRA—Nuclear Receptors—ESR1—uterine cancer	0.00192	0.00409	CbGpPWpGaD
Adapalene—Herpes simplex—Doxorubicin—uterine cancer	0.00189	0.00635	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.00188	0.004	CbGpPWpGaD
Adapalene—RARG—Retinoic acid receptors-mediated signaling—AKT1—uterine cancer	0.00187	0.00398	CbGpPWpGaD
Adapalene—Urticaria—Progesterone—uterine cancer	0.00186	0.00626	CcSEcCtD
Adapalene—Dermatitis contact—Epirubicin—uterine cancer	0.00186	0.00625	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.00181	0.00384	CbGpPWpGaD
Adapalene—Skin exfoliation—Epirubicin—uterine cancer	0.0018	0.00604	CcSEcCtD
Adapalene—RXRG—Adipogenesis—SMAD3—uterine cancer	0.0018	0.00383	CbGpPWpGaD
Adapalene—RXRG—Regulation of Androgen receptor activity—EP300—uterine cancer	0.0018	0.00382	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.00175	0.00371	CbGpPWpGaD
Adapalene—Hypersensitivity—Progesterone—uterine cancer	0.00173	0.0058	CcSEcCtD
Adapalene—Dermatitis contact—Doxorubicin—uterine cancer	0.00172	0.00579	CcSEcCtD
Adapalene—RXRG—Retinoic acid receptors-mediated signaling—AKT1—uterine cancer	0.00171	0.00364	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—SMAD3—uterine cancer	0.00169	0.0036	CbGpPWpGaD
Adapalene—RXRB—Regulation of Androgen receptor activity—EP300—uterine cancer	0.00169	0.00359	CbGpPWpGaD
Adapalene—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00169	0.00567	CcSEcCtD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—MET—uterine cancer	0.00169	0.00359	CbGpPWpGaD
Adapalene—RARB—Retinoic acid receptors-mediated signaling—AKT1—uterine cancer	0.00168	0.00357	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.00167	0.00356	CbGpPWpGaD
Adapalene—Skin exfoliation—Doxorubicin—uterine cancer	0.00167	0.00559	CcSEcCtD
Adapalene—Pruritus—Progesterone—uterine cancer	0.00166	0.00557	CcSEcCtD
Adapalene—RXRA—REV-ERBA represses gene expression—EP300—uterine cancer	0.00166	0.00353	CbGpPWpGaD
Adapalene—RXRA—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.00162	0.00345	CbGpPWpGaD
Adapalene—RXRB—Retinoic acid receptors-mediated signaling—AKT1—uterine cancer	0.00161	0.00342	CbGpPWpGaD
Adapalene—RARA—Retinoic acid receptors-mediated signaling—AKT1—uterine cancer	0.00161	0.00342	CbGpPWpGaD
Adapalene—RXRA—RORA activates circadian gene expression—EP300—uterine cancer	0.00161	0.00342	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.00159	0.00337	CbGpPWpGaD
Adapalene—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00157	0.00526	CcSEcCtD
Adapalene—Eczema—Epirubicin—uterine cancer	0.00152	0.00511	CcSEcCtD
Adapalene—RXRA—Nuclear Receptor transcription pathway—ESR1—uterine cancer	0.00152	0.00323	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.00152	0.00323	CbGpPWpGaD
Adapalene—Eye pain—Epirubicin—uterine cancer	0.00152	0.00509	CcSEcCtD
Adapalene—RXRG—a6b1 and a6b4 Integrin signaling—PIK3CA—uterine cancer	0.00152	0.00322	CbGpPWpGaD
Adapalene—RXRA—NRF2 pathway—NFE2L2—uterine cancer	0.00151	0.0032	CbGpPWpGaD
Adapalene—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.0015	0.00505	CcSEcCtD
Adapalene—RARG—Gene Expression—PHF1—uterine cancer	0.00149	0.00317	CbGpPWpGaD
Adapalene—Rash—Progesterone—uterine cancer	0.00148	0.00496	CcSEcCtD
Adapalene—Dermatitis—Progesterone—uterine cancer	0.00148	0.00496	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.00147	0.00312	CbGpPWpGaD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—CDH1—uterine cancer	0.00146	0.00311	CbGpPWpGaD
Adapalene—Dermatitis exfoliative—Epirubicin—uterine cancer	0.00145	0.00487	CcSEcCtD
Adapalene—RXRA—NRF2 pathway—GPX3—uterine cancer	0.00144	0.00306	CbGpPWpGaD
Adapalene—Dermatitis bullous—Epirubicin—uterine cancer	0.00143	0.00481	CcSEcCtD
Adapalene—RXRB—a6b1 and a6b4 Integrin signaling—PIK3CA—uterine cancer	0.00142	0.00303	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.00142	0.00302	CbGpPWpGaD
Adapalene—Pain—Dactinomycin—uterine cancer	0.00142	0.00476	CcSEcCtD
Adapalene—Eczema—Doxorubicin—uterine cancer	0.00141	0.00473	CcSEcCtD
Adapalene—Eye pain—Doxorubicin—uterine cancer	0.0014	0.00471	CcSEcCtD
Adapalene—RXRG—a6b1 and a6b4 Integrin signaling—HRAS—uterine cancer	0.0014	0.00298	CbGpPWpGaD
Adapalene—RXRA—Retinoic acid receptors-mediated signaling—EP300—uterine cancer	0.00139	0.00295	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—PHF1—uterine cancer	0.00136	0.0029	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.00136	0.0029	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—HMGA1—uterine cancer	0.00135	0.00287	CbGpPWpGaD
Adapalene—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.00134	0.0045	CcSEcCtD
Adapalene—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.0045	CcSEcCtD
Adapalene—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00449	CcSEcCtD
Adapalene—RARB—Gene Expression—PHF1—uterine cancer	0.00134	0.00284	CbGpPWpGaD
Adapalene—Dermatitis bullous—Doxorubicin—uterine cancer	0.00133	0.00445	CcSEcCtD
Adapalene—Face oedema—Epirubicin—uterine cancer	0.00132	0.00443	CcSEcCtD
Adapalene—RXRB—a6b1 and a6b4 Integrin signaling—HRAS—uterine cancer	0.00132	0.0028	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—PLXNA3—uterine cancer	0.00131	0.00278	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—PHF1—uterine cancer	0.00128	0.00272	CbGpPWpGaD
Adapalene—RARA—Gene Expression—PHF1—uterine cancer	0.00128	0.00272	CbGpPWpGaD
Adapalene—Convulsion—Etoposide—uterine cancer	0.00127	0.00428	CcSEcCtD
Adapalene—RARG—Gene Expression—CHD4—uterine cancer	0.00127	0.00269	CbGpPWpGaD
Adapalene—Dry skin—Epirubicin—uterine cancer	0.00125	0.00421	CcSEcCtD
Adapalene—RXRG—a6b1 and a6b4 Integrin signaling—AKT1—uterine cancer	0.00124	0.00263	CbGpPWpGaD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—ERBB2—uterine cancer	0.00123	0.00262	CbGpPWpGaD
Adapalene—Face oedema—Doxorubicin—uterine cancer	0.00122	0.0041	CcSEcCtD
Adapalene—Hypersensitivity—Dactinomycin—uterine cancer	0.00122	0.0041	CcSEcCtD
Adapalene—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—uterine cancer	0.00117	0.0025	CbGpPWpGaD
Adapalene—RXRA—Biological oxidations—CYP11A1—uterine cancer	0.00117	0.00249	CbGpPWpGaD
Adapalene—RXRB—a6b1 and a6b4 Integrin signaling—AKT1—uterine cancer	0.00116	0.00247	CbGpPWpGaD
Adapalene—Dry skin—Doxorubicin—uterine cancer	0.00116	0.0039	CcSEcCtD
Adapalene—RXRG—Gene Expression—CHD4—uterine cancer	0.00116	0.00246	CbGpPWpGaD
Adapalene—RARB—Gene Expression—CHD4—uterine cancer	0.00114	0.00242	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—PGR—uterine cancer	0.0011	0.00233	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—CHD4—uterine cancer	0.00109	0.00232	CbGpPWpGaD
Adapalene—RARA—Gene Expression—CHD4—uterine cancer	0.00109	0.00232	CbGpPWpGaD
Adapalene—Photosensitivity reaction—Epirubicin—uterine cancer	0.00108	0.00362	CcSEcCtD
Adapalene—RARG—Gene Expression—SUZ12—uterine cancer	0.00106	0.00226	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.00106	0.00225	CbGpPWpGaD
Adapalene—Rash—Dactinomycin—uterine cancer	0.00105	0.00351	CcSEcCtD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.00104	0.00221	CbGpPWpGaD
Adapalene—Pain—Etoposide—uterine cancer	0.00103	0.00344	CcSEcCtD
Adapalene—Conjunctivitis—Epirubicin—uterine cancer	0.00103	0.00344	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.00101	0.00216	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—SOCS3—uterine cancer	0.00101	0.00215	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—PGR—uterine cancer	0.001	0.00214	CbGpPWpGaD
Adapalene—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000999	0.00335	CcSEcCtD
Adapalene—RARB—Generic Transcription Pathway—PGR—uterine cancer	0.000985	0.00209	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—SUZ12—uterine cancer	0.000971	0.00206	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—ESR2—uterine cancer	0.000967	0.00206	CbGpPWpGaD
Adapalene—Urticaria—Etoposide—uterine cancer	0.000953	0.0032	CcSEcCtD
Adapalene—RARB—Gene Expression—SUZ12—uterine cancer	0.000952	0.00202	CbGpPWpGaD
Adapalene—Conjunctivitis—Doxorubicin—uterine cancer	0.000949	0.00318	CcSEcCtD
Adapalene—Hepatitis—Epirubicin—uterine cancer	0.000947	0.00318	CcSEcCtD
Adapalene—RARA—Generic Transcription Pathway—PGR—uterine cancer	0.000944	0.00201	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—PGR—uterine cancer	0.000944	0.00201	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—CTNNB1—uterine cancer	0.000943	0.00201	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.000941	0.002	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—SUZ12—uterine cancer	0.000913	0.00194	CbGpPWpGaD
Adapalene—RARA—Gene Expression—SUZ12—uterine cancer	0.000913	0.00194	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—CTNNB1—uterine cancer	0.000887	0.00189	CbGpPWpGaD
Adapalene—Hypersensitivity—Etoposide—uterine cancer	0.000884	0.00297	CcSEcCtD
Adapalene—RXRG—Generic Transcription Pathway—ESR2—uterine cancer	0.000884	0.00188	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—SMAD3—uterine cancer	0.000882	0.00187	CbGpPWpGaD
Adapalene—RXRA—Regulation of Androgen receptor activity—EP300—uterine cancer	0.00088	0.00187	CbGpPWpGaD
Adapalene—Hepatitis—Doxorubicin—uterine cancer	0.000876	0.00294	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.000872	0.00185	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—ESR2—uterine cancer	0.000867	0.00184	CbGpPWpGaD
Adapalene—RXRA—Biological oxidations—CYP19A1—uterine cancer	0.000861	0.00183	CbGpPWpGaD
Adapalene—RXRA—Circadian Clock—EP300—uterine cancer	0.000855	0.00182	CbGpPWpGaD
Adapalene—Pruritus—Etoposide—uterine cancer	0.000849	0.00285	CcSEcCtD
Adapalene—RXRA—Retinoic acid receptors-mediated signaling—AKT1—uterine cancer	0.000839	0.00178	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—ESR2—uterine cancer	0.000831	0.00177	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—ESR2—uterine cancer	0.000831	0.00177	CbGpPWpGaD
Adapalene—Erythema—Epirubicin—uterine cancer	0.000824	0.00277	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.000792	0.00168	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—CDKN2B—uterine cancer	0.000787	0.00167	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.000777	0.00165	CbGpPWpGaD
Adapalene—Erythema—Doxorubicin—uterine cancer	0.000763	0.00256	CcSEcCtD
Adapalene—Rash—Etoposide—uterine cancer	0.000757	0.00254	CcSEcCtD
Adapalene—Dermatitis—Etoposide—uterine cancer	0.000756	0.00254	CcSEcCtD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000751	0.0016	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000751	0.0016	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.000745	0.00158	CbGpPWpGaD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—PIK3CA—uterine cancer	0.000742	0.00158	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—CDKN2B—uterine cancer	0.00072	0.00153	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.00072	0.00153	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—SMAD3—uterine cancer	0.000718	0.00153	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000714	0.00152	CbGpPWpGaD
Adapalene—Convulsion—Epirubicin—uterine cancer	0.000714	0.0024	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.00071	0.00151	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—CDKN2B—uterine cancer	0.000706	0.0015	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.00069	0.00147	CbGpPWpGaD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—uterine cancer	0.000687	0.00146	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—HNF1B—uterine cancer	0.000686	0.00146	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.00068	0.00145	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—CDKN2B—uterine cancer	0.000677	0.00144	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—CDKN2B—uterine cancer	0.000677	0.00144	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—PHF1—uterine cancer	0.000668	0.00142	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.000663	0.00141	CbGpPWpGaD
Adapalene—Convulsion—Doxorubicin—uterine cancer	0.000661	0.00222	CcSEcCtD
Adapalene—RXRG—Generic Transcription Pathway—SMAD3—uterine cancer	0.000657	0.0014	CbGpPWpGaD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—EP300—uterine cancer	0.000653	0.00139	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.000652	0.00139	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—SMAD3—uterine cancer	0.000644	0.00137	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.000635	0.00135	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.000632	0.00134	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—SMAD3—uterine cancer	0.000618	0.00131	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—SMAD3—uterine cancer	0.000618	0.00131	CbGpPWpGaD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—AKT1—uterine cancer	0.000607	0.00129	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.000606	0.00129	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.000598	0.00127	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—ESR1—uterine cancer	0.000586	0.00125	CbGpPWpGaD
Adapalene—Pain—Epirubicin—uterine cancer	0.000575	0.00193	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.000574	0.00122	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—CHD4—uterine cancer	0.000568	0.00121	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000551	0.00117	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—ESR1—uterine cancer	0.000536	0.00114	CbGpPWpGaD
Adapalene—Urticaria—Epirubicin—uterine cancer	0.000534	0.00179	CcSEcCtD
Adapalene—Pain—Doxorubicin—uterine cancer	0.000532	0.00179	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.000529	0.00112	CbGpPWpGaD
Adapalene—RARG—Gene Expression—PGR—uterine cancer	0.000529	0.00112	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—ESR1—uterine cancer	0.000526	0.00112	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.000509	0.00108	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—ESR1—uterine cancer	0.000504	0.00107	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—ESR1—uterine cancer	0.000504	0.00107	CbGpPWpGaD
Adapalene—RARG—Gene Expression—EZH2—uterine cancer	0.000502	0.00107	CbGpPWpGaD
Adapalene—Hypersensitivity—Epirubicin—uterine cancer	0.000496	0.00166	CcSEcCtD
Adapalene—Urticaria—Doxorubicin—uterine cancer	0.000494	0.00166	CcSEcCtD
Adapalene—RXRA—Generic Transcription Pathway—PGR—uterine cancer	0.000492	0.00105	CbGpPWpGaD
Adapalene—RXRA—PPARA activates gene expression—EP300—uterine cancer	0.000491	0.00104	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.000488	0.00104	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—PGR—uterine cancer	0.000484	0.00103	CbGpPWpGaD
Adapalene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	0.00048	0.00102	CbGpPWpGaD
Adapalene—Pruritus—Epirubicin—uterine cancer	0.000476	0.0016	CcSEcCtD
Adapalene—RXRA—Gene Expression—SUZ12—uterine cancer	0.000476	0.00101	CbGpPWpGaD
Adapalene—RARB—Gene Expression—PGR—uterine cancer	0.000474	0.00101	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	0.000467	0.000994	CbGpPWpGaD
Adapalene—RARG—Gene Expression—ESR2—uterine cancer	0.000465	0.00099	CbGpPWpGaD
Adapalene—RXRA—Metabolism—SRD5A2—uterine cancer	0.000463	0.000984	CbGpPWpGaD
Adapalene—RXRA—Metabolism—NDUFB11—uterine cancer	0.000463	0.000984	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—CTNNB1—uterine cancer	0.000462	0.000983	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—EZH2—uterine cancer	0.000459	0.000976	CbGpPWpGaD
Adapalene—Hypersensitivity—Doxorubicin—uterine cancer	0.000459	0.00154	CcSEcCtD
Adapalene—RARA—Gene Expression—PGR—uterine cancer	0.000455	0.000967	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—PGR—uterine cancer	0.000455	0.000967	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	0.000452	0.000962	CbGpPWpGaD
Adapalene—RARB—Gene Expression—EZH2—uterine cancer	0.00045	0.000958	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000449	0.000956	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	0.000448	0.000953	CbGpPWpGaD
Adapalene—Pruritus—Doxorubicin—uterine cancer	0.00044	0.00148	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	0.000434	0.000922	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—ESR2—uterine cancer	0.000433	0.000921	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—EZH2—uterine cancer	0.000432	0.000918	CbGpPWpGaD
Adapalene—RARA—Gene Expression—EZH2—uterine cancer	0.000432	0.000918	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—ESR2—uterine cancer	0.000426	0.000905	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000424	0.000903	CbGpPWpGaD
Adapalene—Rash—Epirubicin—uterine cancer	0.000424	0.00142	CcSEcCtD
Adapalene—Dermatitis—Epirubicin—uterine cancer	0.000424	0.00142	CcSEcCtD
Adapalene—RARB—Gene Expression—ESR2—uterine cancer	0.000417	0.000888	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—ESR2—uterine cancer	0.0004	0.000851	CbGpPWpGaD
Adapalene—RARA—Gene Expression—ESR2—uterine cancer	0.0004	0.000851	CbGpPWpGaD
Adapalene—Rash—Doxorubicin—uterine cancer	0.000392	0.00132	CcSEcCtD
Adapalene—Dermatitis—Doxorubicin—uterine cancer	0.000392	0.00132	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.000388	0.000826	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	0.000382	0.000812	CbGpPWpGaD
Adapalene—RARG—Gene Expression—CDKN2B—uterine cancer	0.000379	0.000806	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	0.000366	0.000778	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.00036	0.000765	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—CDKN2B—uterine cancer	0.000353	0.00075	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—CDKN2B—uterine cancer	0.000347	0.000737	CbGpPWpGaD
Adapalene—RARG—Gene Expression—SMAD3—uterine cancer	0.000346	0.000736	CbGpPWpGaD
Adapalene—RARB—Gene Expression—CDKN2B—uterine cancer	0.00034	0.000723	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.00034	0.000722	CbGpPWpGaD
Adapalene—RXRA—Metabolism—AKR1B1—uterine cancer	0.000335	0.000711	CbGpPWpGaD
Adapalene—RXRA—Metabolism—STAR—uterine cancer	0.000335	0.000711	CbGpPWpGaD
Adapalene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	0.000331	0.000704	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.000331	0.000704	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000331	0.000703	CbGpPWpGaD
Adapalene—RARA—Gene Expression—CDKN2B—uterine cancer	0.000326	0.000693	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—CDKN2B—uterine cancer	0.000326	0.000693	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—SMAD3—uterine cancer	0.000322	0.000685	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—SMAD3—uterine cancer	0.000316	0.000673	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.000316	0.000671	CbGpPWpGaD
Adapalene—RARB—Gene Expression—SMAD3—uterine cancer	0.00031	0.00066	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—SMAD3—uterine cancer	0.000303	0.000644	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.000299	0.000636	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—SMAD3—uterine cancer	0.000297	0.000632	CbGpPWpGaD
Adapalene—RARA—Gene Expression—SMAD3—uterine cancer	0.000297	0.000632	CbGpPWpGaD
Adapalene—RARG—Gene Expression—ESR1—uterine cancer	0.000282	0.0006	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—ESR1—uterine cancer	0.000263	0.000559	CbGpPWpGaD
Adapalene—RXRA—Metabolism—POLD1—uterine cancer	0.000263	0.000558	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—ESR1—uterine cancer	0.000258	0.000549	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.000254	0.000541	CbGpPWpGaD
Adapalene—RARB—Gene Expression—ESR1—uterine cancer	0.000253	0.000538	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—MET—uterine cancer	0.000248	0.000528	CbGpPWpGaD
Adapalene—RXRA—Metabolism—AKR1C1—uterine cancer	0.000246	0.000522	CbGpPWpGaD
Adapalene—RARA—Gene Expression—ESR1—uterine cancer	0.000243	0.000516	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—ESR1—uterine cancer	0.000243	0.000516	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—PGR—uterine cancer	0.000237	0.000504	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	0.000234	0.000497	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	0.000226	0.00048	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—EZH2—uterine cancer	0.000225	0.000478	CbGpPWpGaD
Adapalene—RXRA—Metabolism—RRM2—uterine cancer	0.000219	0.000465	CbGpPWpGaD
Adapalene—RXRA—Metabolism—DCN—uterine cancer	0.000212	0.000452	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—ESR2—uterine cancer	0.000209	0.000444	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CYP11A1—uterine cancer	0.0002	0.000426	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	0.000191	0.000406	CbGpPWpGaD
Adapalene—RXRA—Metabolism—AKR1C3—uterine cancer	0.000189	0.000402	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—ERBB2—uterine cancer	0.000182	0.000386	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—CDKN2B—uterine cancer	0.00017	0.000361	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—CTNNB1—uterine cancer	0.000159	0.000338	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—SMAD3—uterine cancer	0.000155	0.00033	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—EP300—uterine cancer	0.000148	0.000314	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CYP19A1—uterine cancer	0.000147	0.000313	CbGpPWpGaD
Adapalene—RXRA—Metabolism—STK11—uterine cancer	0.000147	0.000313	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—VEGFA—uterine cancer	0.00014	0.000297	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000138	0.000294	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—NRAS—uterine cancer	0.000138	0.000294	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000132	0.00028	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—ESR1—uterine cancer	0.000127	0.000269	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—KRAS—uterine cancer	0.000119	0.000253	CbGpPWpGaD
Adapalene—RXRA—Metabolism—MTHFR—uterine cancer	0.000111	0.000235	CbGpPWpGaD
Adapalene—RARG—Gene Expression—AKT1—uterine cancer	0.000102	0.000217	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—HRAS—uterine cancer	0.000101	0.000215	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.75e-05	0.000207	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—AKT1—uterine cancer	9.31e-05	0.000198	CbGpPWpGaD
Adapalene—RARB—Gene Expression—AKT1—uterine cancer	9.13e-05	0.000194	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—AKT1—uterine cancer	8.92e-05	0.00019	CbGpPWpGaD
Adapalene—RARA—Gene Expression—AKT1—uterine cancer	8.76e-05	0.000186	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—AKT1—uterine cancer	8.76e-05	0.000186	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PTEN—uterine cancer	6.16e-05	0.000131	CbGpPWpGaD
Adapalene—RXRA—Metabolism—EP300—uterine cancer	5.87e-05	0.000125	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—AKT1—uterine cancer	4.56e-05	9.7e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PIK3CA—uterine cancer	4.34e-05	9.24e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—AKT1—uterine cancer	3.55e-05	7.54e-05	CbGpPWpGaD
